Funder: National Institutes of Health
Due Dates: May 13, 2025 | September 15, 2025 | January 13, 2026 | May 13, 2026 | September 14, 2026 | January 13, 2027
Funding Amounts: No budget cap; project period up to 5 years; budgets must reflect actual needs of the proposed high-risk clinical trial.
Summary: Supports investigator-initiated, high-risk clinical trials and mechanistic studies in NIAID priority areas; one clinical trial per application.
Key Information: All planning must be complete at submission; prior consultation with NIAID is required for budgets ≥$500,000 direct costs/year.